1. Home
  2. TH vs GERN Comparison

TH vs GERN Comparison

Compare TH & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TH
  • GERN
  • Stock Information
  • Founded
  • TH 1978
  • GERN 1990
  • Country
  • TH United States
  • GERN United States
  • Employees
  • TH N/A
  • GERN N/A
  • Industry
  • TH Hotels/Resorts
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • TH Consumer Discretionary
  • GERN Health Care
  • Exchange
  • TH Nasdaq
  • GERN Nasdaq
  • Market Cap
  • TH 714.4M
  • GERN 823.0M
  • IPO Year
  • TH N/A
  • GERN 1996
  • Fundamental
  • Price
  • TH $6.77
  • GERN $1.09
  • Analyst Decision
  • TH Buy
  • GERN Buy
  • Analyst Count
  • TH 3
  • GERN 7
  • Target Price
  • TH $13.00
  • GERN $3.00
  • AVG Volume (30 Days)
  • TH 380.6K
  • GERN 8.2M
  • Earning Date
  • TH 11-06-2025
  • GERN 11-05-2025
  • Dividend Yield
  • TH N/A
  • GERN N/A
  • EPS Growth
  • TH N/A
  • GERN N/A
  • EPS
  • TH 0.10
  • GERN N/A
  • Revenue
  • TH $310,382,000.00
  • GERN $183,403,000.00
  • Revenue This Year
  • TH N/A
  • GERN $166.20
  • Revenue Next Year
  • TH N/A
  • GERN $55.83
  • P/E Ratio
  • TH $74.02
  • GERN N/A
  • Revenue Growth
  • TH N/A
  • GERN 522.13
  • 52 Week Low
  • TH $4.00
  • GERN $1.04
  • 52 Week High
  • TH $11.10
  • GERN $4.50
  • Technical
  • Relative Strength Index (RSI)
  • TH 37.09
  • GERN 33.62
  • Support Level
  • TH $7.09
  • GERN $1.04
  • Resistance Level
  • TH $7.84
  • GERN $1.29
  • Average True Range (ATR)
  • TH 0.43
  • GERN 0.06
  • MACD
  • TH 0.03
  • GERN -0.02
  • Stochastic Oscillator
  • TH 8.09
  • GERN 20.37

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. Its operating segment includes HFS-South and HFS-Midwest; Government; TCPL Keystone and others. It generates a majority of its revenue from the Government segment which consists of specialty rental and vertically integrated hospitality services revenue from customers with Government contracts located in Texas.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: